About imito
imito is a Swiss-based healthcare technology company and established pioneer in the field of mobile clinical applications. The company specializes in developing innovative digital solutions that simplify medical documentation for healthcare professionals, with a particular focus on wound management and medical photography.
Their product portfolio includes imitoCam for medical photo and video documentation, imitoWound for AI-powered wound documentation and measurement, WoundGenius as their next-generation wound assessment tool, and imitoScan for scanning patient documents. imito serves over 60 hospitals across Europe, integrating seamlessly with existing healthcare infrastructure through standards-based connections including FHIR, HL7, LDAP SAML, and DICOM protocols. The company's scientifically validated wound measurement methods have been peer-reviewed and published in reputable medical journals. With a mission to improve patient care through better clinical documentation, imito empowers healthcare professionals across more than 35 medical professions to document findings efficiently and accurately.
FAQs
- When was imito founded?
- imito was founded in 2016.
- What industries or markets does imito operate in?
- imito operates in the following markets: Healthcare Technology, Medical Software, Digital Health, Wound Care, Medical Imaging, Clinical Documentation, AI in Healthcare, Mobile Health, and Medical Devices.
- How many employees does imito have?
- imito has 11-50 employees.
- Where does imito have employees?
- imito has employees in Switzerland.
- Is imito hiring?
- Yes, imito has 1 open remote job.
- Does imito support remote work or working from home?
- Yes, imito is a remote-friendly company.
- What employee benefits does imito offer?
- imito provides 4 benefits to their employees.
- Does imito offer a four-day work week?
- No, imito does not offer a four-day work week.
- What is imito's website?
- imito's website is imito.io.
- Where can I find imito on social media?
- You can find imito on LinkedIn.